Kanber Eyüp Murat, Gulmez Harun
Department of Cardiovascular Surgery, Private Hospital, Istanbul, TUR.
Department of Cardiovascular Surgery, Private Gurlife Hospital, Istanbul, TUR.
Cureus. 2023 Jun 22;15(6):e40803. doi: 10.7759/cureus.40803. eCollection 2023 Jun.
Introduction Diabetic foot ulcers (DFU) are one of the most common complications of diabetes mellitus (DM). The use of platelet-rich plasma (PRP) in the treatment of DFU has been increasing in recent years. In the current study, we aimed to evaluate the factors affecting the success of PRP in the management of DFU. Methods The present study was planned in a prospective manner, and we enrolled patients with DFU in the study. Patients' characteristics, DFU properties, and treatment outcomes were recorded. Patients with DFU were classified into two groups according to PRP success: healed DFU patients in Group 1 and non-healed DFU patients in Group 2. Groups were compared according to patient characteristics and treatment outcomes, and multivariate regression analysis was performed to clarify factors that predicted PRP success. Results In total, 182 patients were enrolled in the study, and DFU in 141 (77.5%) patients healed with PRP treatment. The mean body mass index (BMI) was significantly higher in the non-healed patients (p= 0.005). The smoking rate was 58.5% in the non-healed group and 39.7% in the healed group (p= 0.016). The duration of DM (17.9 years vs. 22.5 years, p= 0.003) was significantly longer, and patients with glomerular filtration rate (GFR) < 60 (44.0% vs. 63.4, p= 0.028) were significantly more common in the non-healed group. Multivariate regression analysis demonstrated that BMI ≥30 kg/mand duration of DM ≥20 years were predictive factors for PRP failure in patients with DFU (p= 0.019 and p= 0.005). Smoking and GFR <60 were significantly associated with PRP failure (p= 0.040 and p= 0.044). Conclusion In our study, it was found that PRP was an effective treatment that improved DFU in 141 out of 182 patients. Moreover, the present study demonstrated for the first time that higher BMI, longer duration of DM, smoking, and lower GFR were significantly related to PRP failure in patients with DFU.
引言 糖尿病足溃疡(DFU)是糖尿病(DM)最常见的并发症之一。近年来,富血小板血浆(PRP)在DFU治疗中的应用不断增加。在本研究中,我们旨在评估影响PRP治疗DFU成功的因素。方法 本研究采用前瞻性设计,纳入DFU患者。记录患者的特征、DFU的特性和治疗结果。根据PRP治疗的成功情况,将DFU患者分为两组:第1组为DFU愈合患者,第2组为DFU未愈合患者。根据患者特征和治疗结果对两组进行比较,并进行多变量回归分析以明确预测PRP治疗成功的因素。结果 本研究共纳入182例患者,141例(77.5%)患者的DFU经PRP治疗后愈合。未愈合患者的平均体重指数(BMI)显著更高(p = 0.005)。未愈合组的吸烟率为58.5%,愈合组为39.7%(p = 0.016)。未愈合组的糖尿病病程(17.9年对22.5年,p = 0.003)显著更长,肾小球滤过率(GFR)<60的患者(44.0%对63.4%,p = 0.028)在未愈合组中显著更常见。多变量回归分析表明,BMI≥30 kg/m²和糖尿病病程≥20年是DFU患者PRP治疗失败的预测因素(p = 0.019和p = 0.005)。吸烟和GFR<60与PRP治疗失败显著相关(p = 0.040和p = 0.044)。结论 在我们的研究中,发现PRP是一种有效的治疗方法,182例患者中有141例DFU得到改善。此外,本研究首次表明,较高的BMI、较长的糖尿病病程、吸烟和较低的GFR与DFU患者PRP治疗失败显著相关。